nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—EBP—Tamoxifen—pancreatic cancer	0.16	0.216	CbGbCtD
Amiodarone—SIGMAR1—Tamoxifen—pancreatic cancer	0.0687	0.0926	CbGbCtD
Amiodarone—CYP1A1—Dacarbazine—pancreatic cancer	0.0307	0.0413	CbGbCtD
Amiodarone—CYP2A6—Tamoxifen—pancreatic cancer	0.0285	0.0385	CbGbCtD
Amiodarone—CYP1A1—Tamoxifen—pancreatic cancer	0.0244	0.0329	CbGbCtD
Amiodarone—KCNH2—Sunitinib—pancreatic cancer	0.0214	0.0288	CbGbCtD
Amiodarone—CYP2A6—Fluorouracil—pancreatic cancer	0.021	0.0283	CbGbCtD
Amiodarone—CYP1A1—Erlotinib—pancreatic cancer	0.0207	0.0279	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0195	0.0263	CbGbCtD
Amiodarone—CYP3A7—Tamoxifen—pancreatic cancer	0.0195	0.0263	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—pancreatic cancer	0.015	0.0202	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.015	0.0202	CbGbCtD
Amiodarone—CYP3A5—Tamoxifen—pancreatic cancer	0.0146	0.0197	CbGbCtD
Amiodarone—CYP2C8—Tamoxifen—pancreatic cancer	0.0141	0.019	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—pancreatic cancer	0.0137	0.0184	CbGbCtD
Amiodarone—CYP3A5—Erlotinib—pancreatic cancer	0.0124	0.0168	CbGbCtD
Amiodarone—CYP2C8—Erlotinib—pancreatic cancer	0.012	0.0161	CbGbCtD
Amiodarone—CYP2C19—Tamoxifen—pancreatic cancer	0.0118	0.0159	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—pancreatic cancer	0.0112	0.0151	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—pancreatic cancer	0.011	0.0148	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.011	0.0148	CbGbCtD
Amiodarone—CYP3A7—Sunitinib—pancreatic cancer	0.0109	0.0147	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0109	0.0147	CbGbCtD
Amiodarone—CYP1A2—Tamoxifen—pancreatic cancer	0.0109	0.0147	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—pancreatic cancer	0.0104	0.014	CbGbCtD
Amiodarone—CYP2C9—Tamoxifen—pancreatic cancer	0.00981	0.0132	CbGbCtD
Amiodarone—ABCB1—Tamoxifen—pancreatic cancer	0.00953	0.0128	CbGbCtD
Amiodarone—CYP1A2—Erlotinib—pancreatic cancer	0.00926	0.0125	CbGbCtD
Amiodarone—CYP2D6—Tamoxifen—pancreatic cancer	0.00898	0.0121	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—pancreatic cancer	0.00824	0.0111	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—pancreatic cancer	0.00821	0.0111	CbGbCtD
Amiodarone—CYP3A5—Sunitinib—pancreatic cancer	0.0082	0.011	CbGbCtD
Amiodarone—ABCB1—Erlotinib—pancreatic cancer	0.0081	0.0109	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—pancreatic cancer	0.00803	0.0108	CbGbCtD
Amiodarone—CYP2D6—Erlotinib—pancreatic cancer	0.00763	0.0103	CbGbCtD
Amiodarone—ABCB1—Irinotecan—pancreatic cancer	0.00731	0.00985	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—pancreatic cancer	0.00723	0.00974	CbGbCtD
Amiodarone—CYP3A4—Tamoxifen—pancreatic cancer	0.00571	0.00769	CbGbCtD
Amiodarone—ABCB1—Docetaxel—pancreatic cancer	0.00536	0.00722	CbGbCtD
Amiodarone—ABCB1—Sunitinib—pancreatic cancer	0.00534	0.00719	CbGbCtD
Amiodarone—CYP3A4—Erlotinib—pancreatic cancer	0.00485	0.00654	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—pancreatic cancer	0.00438	0.0059	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—pancreatic cancer	0.004	0.00538	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—pancreatic cancer	0.00376	0.00507	CbGbCtD
Amiodarone—CYP3A4—Docetaxel—pancreatic cancer	0.00321	0.00433	CbGbCtD
Amiodarone—CYP3A4—Sunitinib—pancreatic cancer	0.0032	0.00431	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—pancreatic cancer	0.00239	0.00323	CbGbCtD
Amiodarone—EBP—Azacitidine—Gemcitabine—pancreatic cancer	0.0011	1	CbGdCrCtD
Amiodarone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000111	0.000531	CcSEcCtD
Amiodarone—Fatigue—Irinotecan—pancreatic cancer	0.000111	0.000531	CcSEcCtD
Amiodarone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000111	0.000529	CcSEcCtD
Amiodarone—Alopecia—Docetaxel—pancreatic cancer	0.000111	0.000529	CcSEcCtD
Amiodarone—Pruritus—Sunitinib—pancreatic cancer	0.00011	0.000529	CcSEcCtD
Amiodarone—Pain—Irinotecan—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Amiodarone—Constipation—Irinotecan—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Amiodarone—Dyspnoea—Fluorouracil—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Amiodarone—Erythema—Docetaxel—pancreatic cancer	0.000109	0.000521	CcSEcCtD
Amiodarone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000109	0.000521	CcSEcCtD
Amiodarone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000108	0.000519	CcSEcCtD
Amiodarone—Nausea—Tamoxifen—pancreatic cancer	0.000108	0.000518	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000108	0.000518	CcSEcCtD
Amiodarone—Fatigue—Gemcitabine—pancreatic cancer	0.000108	0.000517	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—pancreatic cancer	0.000108	0.000515	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000108	0.000515	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000107	0.000514	CcSEcCtD
Amiodarone—Constipation—Gemcitabine—pancreatic cancer	0.000107	0.000513	CcSEcCtD
Amiodarone—Pain—Gemcitabine—pancreatic cancer	0.000107	0.000513	CcSEcCtD
Amiodarone—Nausea—Erlotinib—pancreatic cancer	0.000107	0.000513	CcSEcCtD
Amiodarone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000107	0.000513	CcSEcCtD
Amiodarone—Diarrhoea—Sunitinib—pancreatic cancer	0.000107	0.000511	CcSEcCtD
Amiodarone—Dysgeusia—Docetaxel—pancreatic cancer	0.000107	0.000511	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000106	0.000509	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—pancreatic cancer	0.000106	0.000508	CcSEcCtD
Amiodarone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000106	0.000507	CcSEcCtD
Amiodarone—Back pain—Docetaxel—pancreatic cancer	0.000105	0.000504	CcSEcCtD
Amiodarone—Pain—Fluorouracil—pancreatic cancer	0.000105	0.000504	CcSEcCtD
Amiodarone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000105	0.000503	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—pancreatic cancer	0.000104	0.0005	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000104	0.000499	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—pancreatic cancer	0.000103	0.000495	CcSEcCtD
Amiodarone—Dizziness—Sunitinib—pancreatic cancer	0.000103	0.000494	CcSEcCtD
Amiodarone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000103	0.000494	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—pancreatic cancer	0.000103	0.000492	CcSEcCtD
Amiodarone—Abdominal pain—Irinotecan—pancreatic cancer	0.000102	0.000487	CcSEcCtD
Amiodarone—Body temperature increased—Irinotecan—pancreatic cancer	0.000102	0.000487	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000102	0.000487	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000102	0.000487	CcSEcCtD
Amiodarone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000102	0.000486	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—pancreatic cancer	0.0001	0.000479	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—pancreatic cancer	9.96e-05	0.000477	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	9.96e-05	0.000477	CcSEcCtD
Amiodarone—Vomiting—Sunitinib—pancreatic cancer	9.93e-05	0.000475	CcSEcCtD
Amiodarone—Body temperature increased—Gemcitabine—pancreatic cancer	9.9e-05	0.000474	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—pancreatic cancer	9.86e-05	0.000472	CcSEcCtD
Amiodarone—Rash—Sunitinib—pancreatic cancer	9.84e-05	0.000471	CcSEcCtD
Amiodarone—Dermatitis—Sunitinib—pancreatic cancer	9.84e-05	0.000471	CcSEcCtD
Amiodarone—Urticaria—Fluorouracil—pancreatic cancer	9.79e-05	0.000468	CcSEcCtD
Amiodarone—Headache—Sunitinib—pancreatic cancer	9.78e-05	0.000468	CcSEcCtD
Amiodarone—Body temperature increased—Fluorouracil—pancreatic cancer	9.74e-05	0.000466	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—pancreatic cancer	9.66e-05	0.000462	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—pancreatic cancer	9.63e-05	0.000461	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—pancreatic cancer	9.6e-05	0.000459	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—pancreatic cancer	9.57e-05	0.000458	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—pancreatic cancer	9.54e-05	0.000457	CcSEcCtD
Amiodarone—Cough—Docetaxel—pancreatic cancer	9.51e-05	0.000455	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—pancreatic cancer	9.5e-05	0.000455	CcSEcCtD
Amiodarone—Hypersensitivity—Irinotecan—pancreatic cancer	9.48e-05	0.000454	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—pancreatic cancer	9.46e-05	0.000453	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	9.32e-05	0.000446	CcSEcCtD
Amiodarone—Nausea—Sunitinib—pancreatic cancer	9.27e-05	0.000444	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—pancreatic cancer	9.27e-05	0.000444	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—pancreatic cancer	9.24e-05	0.000442	CcSEcCtD
Amiodarone—Asthenia—Irinotecan—pancreatic cancer	9.23e-05	0.000442	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—pancreatic cancer	9.22e-05	0.000441	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—pancreatic cancer	9.17e-05	0.000439	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—pancreatic cancer	9.12e-05	0.000437	CcSEcCtD
Amiodarone—Hypersensitivity—Fluorouracil—pancreatic cancer	9.08e-05	0.000434	CcSEcCtD
Amiodarone—Dry mouth—Docetaxel—pancreatic cancer	9.07e-05	0.000434	CcSEcCtD
Amiodarone—Sweating—Epirubicin—pancreatic cancer	9.01e-05	0.000431	CcSEcCtD
Amiodarone—Asthenia—Gemcitabine—pancreatic cancer	8.99e-05	0.00043	CcSEcCtD
Amiodarone—Confusional state—Docetaxel—pancreatic cancer	8.96e-05	0.000429	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.91e-05	0.000426	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—pancreatic cancer	8.89e-05	0.000426	CcSEcCtD
Amiodarone—Oedema—Docetaxel—pancreatic cancer	8.89e-05	0.000426	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—pancreatic cancer	8.88e-05	0.000425	CcSEcCtD
Amiodarone—Pruritus—Gemcitabine—pancreatic cancer	8.86e-05	0.000424	CcSEcCtD
Amiodarone—Infection—Docetaxel—pancreatic cancer	8.83e-05	0.000423	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—pancreatic cancer	8.83e-05	0.000423	CcSEcCtD
Amiodarone—Diarrhoea—Irinotecan—pancreatic cancer	8.8e-05	0.000421	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—pancreatic cancer	8.77e-05	0.00042	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—pancreatic cancer	8.75e-05	0.000419	CcSEcCtD
Amiodarone—Shock—Docetaxel—pancreatic cancer	8.75e-05	0.000419	CcSEcCtD
Amiodarone—Pruritus—Fluorouracil—pancreatic cancer	8.72e-05	0.000417	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—pancreatic cancer	8.7e-05	0.000417	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—pancreatic cancer	8.68e-05	0.000415	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—pancreatic cancer	8.64e-05	0.000413	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.63e-05	0.000413	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—pancreatic cancer	8.59e-05	0.000411	CcSEcCtD
Amiodarone—Diarrhoea—Gemcitabine—pancreatic cancer	8.57e-05	0.00041	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—pancreatic cancer	8.55e-05	0.000409	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.53e-05	0.000408	CcSEcCtD
Amiodarone—Dizziness—Irinotecan—pancreatic cancer	8.5e-05	0.000407	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—pancreatic cancer	8.48e-05	0.000406	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—pancreatic cancer	8.47e-05	0.000406	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—pancreatic cancer	8.44e-05	0.000404	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—pancreatic cancer	8.43e-05	0.000403	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—pancreatic cancer	8.34e-05	0.000399	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—pancreatic cancer	8.31e-05	0.000398	CcSEcCtD
Amiodarone—Vomiting—Irinotecan—pancreatic cancer	8.18e-05	0.000391	CcSEcCtD
Amiodarone—Dizziness—Fluorouracil—pancreatic cancer	8.15e-05	0.00039	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—pancreatic cancer	8.13e-05	0.000389	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—pancreatic cancer	8.12e-05	0.000389	CcSEcCtD
Amiodarone—Rash—Irinotecan—pancreatic cancer	8.11e-05	0.000388	CcSEcCtD
Amiodarone—Dermatitis—Irinotecan—pancreatic cancer	8.1e-05	0.000388	CcSEcCtD
Amiodarone—Headache—Irinotecan—pancreatic cancer	8.06e-05	0.000386	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—pancreatic cancer	8.04e-05	0.000385	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—pancreatic cancer	7.98e-05	0.000382	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—pancreatic cancer	7.98e-05	0.000382	CcSEcCtD
Amiodarone—Vomiting—Gemcitabine—pancreatic cancer	7.97e-05	0.000381	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—pancreatic cancer	7.95e-05	0.000381	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—pancreatic cancer	7.93e-05	0.000379	CcSEcCtD
Amiodarone—Rash—Gemcitabine—pancreatic cancer	7.9e-05	0.000378	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—pancreatic cancer	7.89e-05	0.000378	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—pancreatic cancer	7.87e-05	0.000377	CcSEcCtD
Amiodarone—Headache—Gemcitabine—pancreatic cancer	7.85e-05	0.000376	CcSEcCtD
Amiodarone—Flushing—Epirubicin—pancreatic cancer	7.83e-05	0.000375	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—pancreatic cancer	7.83e-05	0.000375	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—pancreatic cancer	7.83e-05	0.000375	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—pancreatic cancer	7.81e-05	0.000374	CcSEcCtD
Amiodarone—Rash—Fluorouracil—pancreatic cancer	7.77e-05	0.000372	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—pancreatic cancer	7.76e-05	0.000371	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—pancreatic cancer	7.73e-05	0.00037	CcSEcCtD
Amiodarone—Headache—Fluorouracil—pancreatic cancer	7.72e-05	0.000369	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.68e-05	0.000367	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—pancreatic cancer	7.67e-05	0.000367	CcSEcCtD
Amiodarone—Nausea—Irinotecan—pancreatic cancer	7.64e-05	0.000366	CcSEcCtD
Amiodarone—Constipation—Docetaxel—pancreatic cancer	7.6e-05	0.000364	CcSEcCtD
Amiodarone—Pain—Docetaxel—pancreatic cancer	7.6e-05	0.000364	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—pancreatic cancer	7.54e-05	0.000361	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—pancreatic cancer	7.53e-05	0.00036	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—pancreatic cancer	7.46e-05	0.000357	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—pancreatic cancer	7.44e-05	0.000356	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—pancreatic cancer	7.38e-05	0.000353	CcSEcCtD
Amiodarone—Erythema—Epirubicin—pancreatic cancer	7.35e-05	0.000352	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—pancreatic cancer	7.33e-05	0.000351	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—pancreatic cancer	7.32e-05	0.00035	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—pancreatic cancer	7.28e-05	0.000349	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.27e-05	0.000348	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—pancreatic cancer	7.25e-05	0.000347	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—pancreatic cancer	7.2e-05	0.000344	CcSEcCtD
Amiodarone—Back pain—Epirubicin—pancreatic cancer	7.11e-05	0.00034	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—pancreatic cancer	7.03e-05	0.000336	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—pancreatic cancer	7.03e-05	0.000336	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—pancreatic cancer	6.98e-05	0.000334	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—pancreatic cancer	6.92e-05	0.000331	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—pancreatic cancer	6.9e-05	0.00033	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—pancreatic cancer	6.82e-05	0.000326	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—pancreatic cancer	6.8e-05	0.000325	CcSEcCtD
Amiodarone—Agitation—Epirubicin—pancreatic cancer	6.75e-05	0.000323	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—pancreatic cancer	6.66e-05	0.000319	CcSEcCtD
Amiodarone—Malaise—Epirubicin—pancreatic cancer	6.63e-05	0.000317	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—pancreatic cancer	6.6e-05	0.000316	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—pancreatic cancer	6.58e-05	0.000315	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—pancreatic cancer	6.55e-05	0.000314	CcSEcCtD
Amiodarone—Cough—Epirubicin—pancreatic cancer	6.41e-05	0.000307	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—pancreatic cancer	6.41e-05	0.000307	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—pancreatic cancer	6.38e-05	0.000305	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.31e-05	0.000302	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—pancreatic cancer	6.29e-05	0.000301	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—pancreatic cancer	6.25e-05	0.000299	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—pancreatic cancer	6.23e-05	0.000298	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—pancreatic cancer	6.18e-05	0.000296	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—pancreatic cancer	6.13e-05	0.000293	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—pancreatic cancer	6.12e-05	0.000293	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—pancreatic cancer	6.11e-05	0.000292	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—pancreatic cancer	6.08e-05	0.000291	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—pancreatic cancer	6.05e-05	0.000289	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—pancreatic cancer	6e-05	0.000287	CcSEcCtD
Amiodarone—Oedema—Epirubicin—pancreatic cancer	6e-05	0.000287	CcSEcCtD
Amiodarone—Infection—Epirubicin—pancreatic cancer	5.96e-05	0.000285	CcSEcCtD
Amiodarone—Cough—Doxorubicin—pancreatic cancer	5.93e-05	0.000284	CcSEcCtD
Amiodarone—Shock—Epirubicin—pancreatic cancer	5.9e-05	0.000282	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—pancreatic cancer	5.88e-05	0.000281	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—pancreatic cancer	5.87e-05	0.000281	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—pancreatic cancer	5.85e-05	0.00028	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—pancreatic cancer	5.82e-05	0.000279	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—pancreatic cancer	5.8e-05	0.000277	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—pancreatic cancer	5.77e-05	0.000276	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—pancreatic cancer	5.72e-05	0.000274	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—pancreatic cancer	5.72e-05	0.000274	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—pancreatic cancer	5.66e-05	0.000271	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—pancreatic cancer	5.65e-05	0.000271	CcSEcCtD
Amiodarone—Rash—Docetaxel—pancreatic cancer	5.61e-05	0.000268	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—pancreatic cancer	5.6e-05	0.000268	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—pancreatic cancer	5.6e-05	0.000268	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—pancreatic cancer	5.59e-05	0.000268	CcSEcCtD
Amiodarone—Headache—Docetaxel—pancreatic cancer	5.57e-05	0.000267	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.55e-05	0.000266	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—pancreatic cancer	5.55e-05	0.000266	CcSEcCtD
Amiodarone—Infection—Doxorubicin—pancreatic cancer	5.51e-05	0.000264	CcSEcCtD
Amiodarone—Shock—Doxorubicin—pancreatic cancer	5.46e-05	0.000261	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.43e-05	0.00026	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—pancreatic cancer	5.42e-05	0.00026	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—pancreatic cancer	5.42e-05	0.000259	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—pancreatic cancer	5.39e-05	0.000258	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—pancreatic cancer	5.38e-05	0.000258	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.36e-05	0.000257	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—pancreatic cancer	5.35e-05	0.000256	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—pancreatic cancer	5.29e-05	0.000253	CcSEcCtD
Amiodarone—Nausea—Docetaxel—pancreatic cancer	5.28e-05	0.000253	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—pancreatic cancer	5.28e-05	0.000253	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—pancreatic cancer	5.21e-05	0.00025	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—pancreatic cancer	5.18e-05	0.000248	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.18e-05	0.000248	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—pancreatic cancer	5.17e-05	0.000247	CcSEcCtD
Amiodarone—Pain—Epirubicin—pancreatic cancer	5.13e-05	0.000245	CcSEcCtD
Amiodarone—Constipation—Epirubicin—pancreatic cancer	5.13e-05	0.000245	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—pancreatic cancer	5.02e-05	0.00024	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—pancreatic cancer	4.98e-05	0.000238	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—pancreatic cancer	4.95e-05	0.000237	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—pancreatic cancer	4.94e-05	0.000237	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.9e-05	0.000235	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—pancreatic cancer	4.88e-05	0.000234	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—pancreatic cancer	4.82e-05	0.000231	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.79e-05	0.000229	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—pancreatic cancer	4.78e-05	0.000229	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—pancreatic cancer	4.76e-05	0.000228	CcSEcCtD
Amiodarone—Pain—Doxorubicin—pancreatic cancer	4.74e-05	0.000227	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—pancreatic cancer	4.74e-05	0.000227	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—pancreatic cancer	4.74e-05	0.000227	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—pancreatic cancer	4.74e-05	0.000227	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—pancreatic cancer	4.57e-05	0.000219	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.54e-05	0.000217	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—pancreatic cancer	4.42e-05	0.000211	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—pancreatic cancer	4.41e-05	0.000211	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—pancreatic cancer	4.39e-05	0.00021	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—pancreatic cancer	4.39e-05	0.00021	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—pancreatic cancer	4.3e-05	0.000206	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—pancreatic cancer	4.24e-05	0.000203	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—pancreatic cancer	4.1e-05	0.000196	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—pancreatic cancer	4.09e-05	0.000196	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—pancreatic cancer	3.98e-05	0.000191	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—pancreatic cancer	3.97e-05	0.00019	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—pancreatic cancer	3.93e-05	0.000188	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—pancreatic cancer	3.81e-05	0.000182	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—pancreatic cancer	3.8e-05	0.000182	CcSEcCtD
Amiodarone—Rash—Epirubicin—pancreatic cancer	3.78e-05	0.000181	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—pancreatic cancer	3.78e-05	0.000181	CcSEcCtD
Amiodarone—Headache—Epirubicin—pancreatic cancer	3.76e-05	0.00018	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—pancreatic cancer	3.67e-05	0.000176	CcSEcCtD
Amiodarone—Nausea—Epirubicin—pancreatic cancer	3.56e-05	0.00017	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—pancreatic cancer	3.53e-05	0.000169	CcSEcCtD
Amiodarone—Rash—Doxorubicin—pancreatic cancer	3.5e-05	0.000167	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—pancreatic cancer	3.5e-05	0.000167	CcSEcCtD
Amiodarone—Headache—Doxorubicin—pancreatic cancer	3.48e-05	0.000166	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—pancreatic cancer	3.3e-05	0.000158	CcSEcCtD
Amiodarone—ADRB1—Signaling Pathways—GCG—pancreatic cancer	1.01e-05	0.000211	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—STK11—pancreatic cancer	9.88e-06	0.000207	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.79e-06	0.000205	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	9.67e-06	0.000203	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	9.6e-06	0.000201	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.57e-06	0.000201	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.47e-06	0.000198	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STK11—pancreatic cancer	9.46e-06	0.000198	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.33e-06	0.000195	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TYMS—pancreatic cancer	9.28e-06	0.000194	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GLP1R—pancreatic cancer	9.25e-06	0.000194	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.24e-06	0.000194	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.18e-06	0.000192	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CA—pancreatic cancer	9.11e-06	0.000191	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.1e-06	0.000191	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—DPYD—pancreatic cancer	9.1e-06	0.000191	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GLP1R—pancreatic cancer	9.03e-06	0.000189	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.02e-06	0.000189	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMP—pancreatic cancer	8.94e-06	0.000187	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.89e-06	0.000186	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—DPYD—pancreatic cancer	8.88e-06	0.000186	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CD44—pancreatic cancer	8.65e-06	0.000181	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.63e-06	0.000181	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.63e-06	0.000181	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.54e-06	0.000179	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.53e-06	0.000179	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	8.51e-06	0.000178	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TYMS—pancreatic cancer	8.5e-06	0.000178	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.43e-06	0.000177	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	8.43e-06	0.000177	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.42e-06	0.000176	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—DPYD—pancreatic cancer	8.37e-06	0.000175	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—DPYD—pancreatic cancer	8.3e-06	0.000174	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GCG—pancreatic cancer	8.29e-06	0.000174	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	8.29e-06	0.000174	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.25e-06	0.000173	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.2e-06	0.000172	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CD44—pancreatic cancer	8.17e-06	0.000171	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HES1—pancreatic cancer	8.09e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8e-06	0.000168	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.94e-06	0.000166	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.93e-06	0.000166	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.89e-06	0.000165	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	7.87e-06	0.000165	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GCG—pancreatic cancer	7.83e-06	0.000164	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—STK11—pancreatic cancer	7.8e-06	0.000163	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.79e-06	0.000163	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.75e-06	0.000162	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.62e-06	0.00016	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOE—pancreatic cancer	7.54e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.52e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.51e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CD44—pancreatic cancer	7.49e-06	0.000157	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	7.45e-06	0.000156	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—pancreatic cancer	7.44e-06	0.000156	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.38e-06	0.000155	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—STK11—pancreatic cancer	7.36e-06	0.000154	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.33e-06	0.000154	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.27e-06	0.000152	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GLP1R—pancreatic cancer	7.21e-06	0.000151	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GCG—pancreatic cancer	7.18e-06	0.00015	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—pancreatic cancer	7.09e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—DPYD—pancreatic cancer	7.09e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOE—pancreatic cancer	6.92e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.91e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.9e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.85e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	6.81e-06	0.000143	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	6.78e-06	0.000142	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	6.76e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—STK11—pancreatic cancer	6.75e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	6.73e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TYMS—pancreatic cancer	6.71e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CD44—pancreatic cancer	6.69e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.66e-06	0.000139	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOE—pancreatic cancer	6.62e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—pancreatic cancer	6.57e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.55e-06	0.000137	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CD44—pancreatic cancer	6.53e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.49e-06	0.000136	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KDR—pancreatic cancer	6.48e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.43e-06	0.000135	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GCG—pancreatic cancer	6.41e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.34e-06	0.000133	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TYMS—pancreatic cancer	6.34e-06	0.000133	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GCG—pancreatic cancer	6.26e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	6.24e-06	0.000131	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	6.17e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD44—pancreatic cancer	6.15e-06	0.000129	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	6.11e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD44—pancreatic cancer	6.1e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—STK11—pancreatic cancer	6.03e-06	0.000126	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—pancreatic cancer	6.02e-06	0.000126	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	5.99e-06	0.000125	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	5.97e-06	0.000125	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	5.97e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.97e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.91e-06	0.000124	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGF—pancreatic cancer	5.9e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GCG—pancreatic cancer	5.9e-06	0.000124	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—STK11—pancreatic cancer	5.88e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.85e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GCG—pancreatic cancer	5.84e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—pancreatic cancer	5.81e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.66e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.56e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—STK11—pancreatic cancer	5.54e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—STK11—pancreatic cancer	5.5e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	5.49e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.47e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—pancreatic cancer	5.45e-06	0.000114	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	5.44e-06	0.000114	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	5.25e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	5.22e-06	0.000109	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD44—pancreatic cancer	5.21e-06	0.000109	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.2e-06	0.000109	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.19e-06	0.000109	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—pancreatic cancer	5.18e-06	0.000109	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	5.17e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.16e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—pancreatic cancer	5.15e-06	0.000108	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	5.14e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.1e-06	0.000107	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—pancreatic cancer	5.06e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.05e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GCG—pancreatic cancer	4.99e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	4.92e-06	0.000103	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.88e-06	0.000102	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	4.78e-06	0.0001	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.77e-06	9.99e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—pancreatic cancer	4.75e-06	9.95e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—pancreatic cancer	4.74e-06	9.93e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.73e-06	9.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—pancreatic cancer	4.72e-06	9.9e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.72e-06	9.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—STK11—pancreatic cancer	4.7e-06	9.84e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	4.65e-06	9.74e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	4.58e-06	9.59e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—pancreatic cancer	4.51e-06	9.44e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—pancreatic cancer	4.49e-06	9.4e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.47e-06	9.37e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.41e-06	9.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	4.4e-06	9.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	4.37e-06	9.16e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	4.33e-06	9.06e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.26e-06	8.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	4.25e-06	8.9e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—pancreatic cancer	4.22e-06	8.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	4.21e-06	8.82e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—pancreatic cancer	4.13e-06	8.66e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—pancreatic cancer	4.12e-06	8.62e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.11e-06	8.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	4.1e-06	8.59e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.09e-06	8.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	4.06e-06	8.5e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.04e-06	8.46e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD44—pancreatic cancer	4.02e-06	8.42e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.99e-06	8.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	3.98e-06	8.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	3.96e-06	8.29e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—pancreatic cancer	3.88e-06	8.12e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	3.86e-06	8.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GCG—pancreatic cancer	3.85e-06	8.08e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—pancreatic cancer	3.84e-06	8.05e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.81e-06	7.97e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.77e-06	7.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.75e-06	7.85e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.74e-06	7.83e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.71e-06	7.78e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.67e-06	7.69e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.67e-06	7.68e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.64e-06	7.62e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STK11—pancreatic cancer	3.62e-06	7.59e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—pancreatic cancer	3.58e-06	7.51e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.57e-06	7.48e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.56e-06	7.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.54e-06	7.41e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.53e-06	7.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.53e-06	7.39e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.5e-06	7.33e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.47e-06	7.27e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.38e-06	7.08e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.35e-06	7.02e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.35e-06	7.01e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.29e-06	6.89e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—pancreatic cancer	3.29e-06	6.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.28e-06	6.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.27e-06	6.84e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.26e-06	6.84e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.26e-06	6.83e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.24e-06	6.78e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.22e-06	6.74e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	3.18e-06	6.66e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.12e-06	6.53e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.11e-06	6.51e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.08e-06	6.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.08e-06	6.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.05e-06	6.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	3.04e-06	6.36e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.96e-06	6.21e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.92e-06	6.11e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.92e-06	6.11e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.89e-06	6.05e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.86e-06	5.99e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.85e-06	5.96e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.82e-06	5.91e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.82e-06	5.91e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.79e-06	5.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.7e-06	5.66e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.68e-06	5.62e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.66e-06	5.57e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.66e-06	5.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.63e-06	5.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.61e-06	5.46e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.6e-06	5.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.58e-06	5.41e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—pancreatic cancer	2.54e-06	5.31e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.52e-06	5.28e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—pancreatic cancer	2.46e-06	5.15e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.38e-06	4.99e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.32e-06	4.85e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.3e-06	4.82e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.3e-06	4.81e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.29e-06	4.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.28e-06	4.78e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.27e-06	4.76e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.25e-06	4.72e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.21e-06	4.63e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.17e-06	4.55e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	4.17e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.96e-06	4.11e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.88e-06	3.93e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.78e-06	3.72e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.77e-06	3.72e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.75e-06	3.67e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.74e-06	3.64e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	3.63e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	3.42e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.63e-06	3.41e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.62e-06	3.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.52e-06	3.17e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.45e-06	3.04e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—pancreatic cancer	1.42e-06	2.97e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.38e-06	2.9e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.34e-06	2.8e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.32e-06	2.77e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.13e-06	2.37e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.73e-07	1.83e-05	CbGpPWpGaD
